|
KMID : 0363220090470060722
|
|
Korean Journal of Dermatology
2009 Volume.47 No. 6 p.722 ~ p.725
|
|
|
A Case of Psoriasiform Drug Eruption Induced by Imatinib Mesylate (GleevecTM).
|
|
Bae You-In
Yun Sook-Jung
Lee Jee-Bum
Kim Seong-Jin
Lee Seung-Chul
Won Young-Ho
|
|
|
Abstract
|
|
|
|
Imatinib mesylate (GleevecTM, formerly known as STI571) is an oral drug that selectively inhibits bcr-abl, c-kit and platelet-derived factor receptor (PDGFR) tyrosine kinase. It has been used for treating chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors. Various adverse cutaneous reactions have been reported, yet the development of psoriasis or a psoriasiform drug eruption by the drug has rarely been reported. We herein report on a case of psoriasiform drug eruption that developed after administering imatinib mesylate to treat CML.
|
|
|
KEYWORD
|
|
|
Imatinib mesylate, Psoriasis
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|